Literature DB >> 8364973

A monoclonal antibody disrupting cell-cell adhesion of rat ascites hepatoma cells.

S Ohshima1, Y Ishimaru, M Honda, S Ohkawara, M Ogawa.   

Abstract

A cell surface-associated adhesive factor (AF) separated from differentiated rat ascites hepatoma AH136B cells (forming cell islands in vivo) has been highly purified by chromatography. AF is assumed to mediate the cell-cell adhesion essential to island formation of the hepatoma cells. A substance, immunologically cross-reactive with AF, is present in the ascites fluid or culture medium of the AH136B cells. Because the substance is almost identical to AF in molecular weight and aggregation-promoting activity, it has been concluded that AF is released into the ascites fluid where it is concentrated. Monoclonal antibodies have been raised against AF purified from ascites fluid of AH136B cells. We have obtained a monoclonal antibody, coded MoAF-6D6, that strongly abolishes the aggregation-promoting activity of AF. When AH136B cell islands are incubated in the presence of Fab fragments of MoAF-6D6, cell detachment from the islands is evident within 24 h. Cell islands following 36-h culture show a distinct dissociation and islands completely lose their organization 48 h after culture. The dissociating effect of MoAF-6D6 is neutralized by the addition of AF. These results suggest that AF plays a significant role in the maintenance of cell islands.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8364973     DOI: 10.1007/bf00312839

Source DB:  PubMed          Journal:  Cell Tissue Res        ISSN: 0302-766X            Impact factor:   5.249


  31 in total

1.  An adhesive glycoprotein from rat ascites hepatoma cells potentiates natural cytotoxic activity by rat spleen cells.

Authors:  J Y Chen; R Kurano; M Hirashima; H Hayashi
Journal:  Immunology       Date:  1986-05       Impact factor: 7.397

2.  A possible mechanism for island formation by rat ascites hepatoma cells with special reference to the function of aggregation factor at the cell surface.

Authors:  Y Ishimaru; K Kudo; Y Koga; H Hayashi
Journal:  J Cancer Res Clin Oncol       Date:  1979-02-19       Impact factor: 4.553

3.  A monoclonal antibody disrupting calcium-dependent cell-cell adhesion of brain tissues: possible role of its target antigen in animal pattern formation.

Authors:  K Hatta; T S Okada; M Takeichi
Journal:  Proc Natl Acad Sci U S A       Date:  1985-05       Impact factor: 11.205

Review 4.  Morphological and biochemical aspects of adhesiveness and dissociation of cancer cells.

Authors:  H Hayashi; Y Ishimaru
Journal:  Int Rev Cytol       Date:  1981

5.  An immunoelectron microscopic study on the distribution of a cell surface-associated adhesive glycoprotein synthesized by rat ascites hepatoma cells.

Authors:  R Hattori; Y Ishimaru; R Kurano; H Hayashi
Journal:  J Cell Sci       Date:  1984-10       Impact factor: 5.285

6.  Purification of a tumour cell aggregation-promotin factor associated with rat ascites hepatoma cell surface.

Authors:  K Kudo; Y Hanaoka; H Hayashi
Journal:  Br J Cancer       Date:  1976-07       Impact factor: 7.640

7.  An electron microscopic study of tumour cell adhesiveness induced by aggregation promoting factor from rat ascites hepatoma cells.

Authors:  Y Ishimaru; H Ishihara; H Hayashi
Journal:  Br J Cancer       Date:  1975-02       Impact factor: 7.640

8.  Characterization of tumour cell aggregation promoting factor from rat ascites hepatoma cells: Separation of two factors with different antigenic property.

Authors:  K Kudo; Y Hanaoka; H Hayashi
Journal:  Br J Cancer       Date:  1976-01       Impact factor: 7.640

9.  The induction of tumour cell adhesiveness and intercellular junctions by a glycoprotein of rat ascites hepatoma cell surface.

Authors:  Y Ishimaru; K Kudo; H Ishihara; H Hayashi
Journal:  Br J Cancer       Date:  1976-10       Impact factor: 7.640

10.  Ultrastructural changes of intercellular junctions in rat ascites hepatoma cells with calcium depletion.

Authors:  H Ishihara; Y Ishimaru; H Hayashi
Journal:  Br J Cancer       Date:  1977-05       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.